Provided by Tiger Trade Technology Pte. Ltd.

TG Therapeutics

30.57
+1.043.52%
Post-market: 30.830.2649+0.87%17:43 EST
Volume:2.36M
Turnover:71.91M
Market Cap:4.85B
PE:11.01
High:30.95
Open:29.54
Low:29.29
Close:29.53
52wk High:46.48
52wk Low:25.28
Shares:158.76M
Float Shares:148.00M
Volume Ratio:2.29
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.78
EPS(LYR):0.1500
ROE:111.96%
ROA:7.97%
PB:7.99
PE(LYR):203.80

Loading ...

Jan 13, 2026

Major Issues Report

Form 8-K - Current report
Nov 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2025

Major Issues Report

Form 8-K - Current report
Sep 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities